SYDNEY, May 29, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that ...
Aura Biosciences will present Phase 1 data on bel-sar for bladder cancer at the EAU Congress and host an investor event. Aura Biosciences, Inc. announced its participation in the 40th Annual European ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback